1. Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome
   R. Zou et al, 2021, Clinical and Translational Oncology CrossRef
2. Comprehensive analysis of genomic alterations, clinical outcomes, putative functions and potential therapeutic value of MMP11 in human breast cancer
   Amritha Sathyanarayanan et al, 2020, Gene Reports CrossRef
3. Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond
   Stella Logotheti et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
4. Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysis
   Yi-Qun Jia et al, 2019, Aging CrossRef
5. Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
   Rongjie Zhang et al, 2022, Frontiers in Pharmacology CrossRef
6. Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates
   Michał Antoszczak et al, 2021, Current Medicinal Chemistry CrossRef
7. IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma
   Hongmei Liu et al, 2022, Frontiers in Oncology CrossRef
8. IDO2-siRNA Carried by Salmonella Combined with Nifuroxazide Attenuates Melanoma Growth
   Tiesuo Zhao et al, 2023, Current Molecular Pharmacology CrossRef
9. Repurposing of Drug Candidates for Treatment of Skin Cancer
   Hernán Cortés et al, 2021, Frontiers in Oncology CrossRef